Carlyle raises $9 billion for US real estate bets
FILE PHOTO: Carlyle signage displays at the office in Manhattan in New York City, U.S., February 26, 2025. REUTERS/Jeenah Moon/File photo
By Isla Binnie
NEW YORK (Reuters) -Carlyle has raised $9 billion for its latest U.S. real estate fund, the investment group told Reuters on Monday, giving it a record fundraising haul to deploy into land and buildings amid tentative signs of recovery in parts of the sector.
Many asset managers have struggled to coax their backers, which include pension funds and other large financial institutions, to put up cash for real estate investments in recent years, as the market digested factors including slumping demand for commercial real estate and offices in the wake of the COVID pandemic.
The amount of private capital raised globally for real estate investments sagged in 2024 to $131 billion, its lowest since 2012, but has started to rebound this year, mainly driven by a few very large fundraising rounds, according to data from PEI Group.
Despite the backdrop, Carlyle's tenth fund of its kind surpassed the $8 billion raised for its predecessor in 2021.
Carlyle's head of U.S. real estate, Rob Stuckey, said investors committed money during "one of the most difficult fundraising environments for real estate in recent memory."
Like the last two funds, this will have no exposure to office, hotels or traditional retail. Stuckey said he aimed to "avoid structurally challenged areas." Instead, Carlyle will put the new funds into the residential, self-storage and industrial sectors.
"This is a compelling moment to invest, as we see improving fundamentals across our target sectors," he said, adding there was less liquidity - meaning fewer buyers or sources of capital for assets - in the market, which also presented an advantage.
(Reporting by Isla Binnie in New York, editing by David French and Chris Reese)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Increasing unusual put option volume: CG DKS ANF HRL RARE URBN NVAX
- Alnylam stock drops on rival heart trial: Why analysts see core business safe
- What to expect from Kevin Warsh today?
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share